| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | carbohydrate binding | EPM2A SIGLEC16 BCAN CHI3L1 CEMIP2 CLEC2L CD22 GYS1 SIGLEC1 LY75 | 4.64e-06 | 310 | 103 | 10 | GO:0030246 |
| GeneOntologyMolecularFunction | semaphorin receptor binding | 5.48e-06 | 23 | 103 | 4 | GO:0030215 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 5.90e-06 | 188 | 103 | 8 | GO:0005201 | |
| GeneOntologyMolecularFunction | chemorepellent activity | 1.44e-05 | 29 | 103 | 4 | GO:0045499 | |
| GeneOntologyMolecularFunction | alpha-1,4-glucan glucosyltransferase (UDP-glucose donor) activity | 7.88e-05 | 3 | 103 | 2 | GO:0004373 | |
| GeneOntologyMolecularFunction | serine-type peptidase activity | 9.93e-05 | 207 | 103 | 7 | GO:0008236 | |
| GeneOntologyMolecularFunction | serine hydrolase activity | 1.15e-04 | 212 | 103 | 7 | GO:0017171 | |
| GeneOntologyMolecularFunction | peptide binding | 2.43e-04 | 318 | 103 | 8 | GO:0042277 | |
| GeneOntologyMolecularFunction | serine-type endopeptidase activity | 4.57e-04 | 190 | 103 | 6 | GO:0004252 | |
| GeneOntologyMolecularFunction | peptidase activity | DPP7 HGF NPEPPS CASP8 MST1 DPEP2 TLL2 MST1L MMP9 MMP17 PCSK4 | 5.56e-04 | 654 | 103 | 11 | GO:0008233 |
| GeneOntologyMolecularFunction | immunoglobulin binding | 8.41e-04 | 36 | 103 | 3 | GO:0019865 | |
| GeneOntologyMolecularFunction | IgM binding | 1.41e-03 | 11 | 103 | 2 | GO:0001791 | |
| GeneOntologyMolecularFunction | aminopeptidase activity | 1.42e-03 | 43 | 103 | 3 | GO:0004177 | |
| GeneOntologyMolecularFunction | platelet-derived growth factor binding | 1.68e-03 | 12 | 103 | 2 | GO:0048407 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent conferring tensile strength | 1.72e-03 | 46 | 103 | 3 | GO:0030020 | |
| GeneOntologyMolecularFunction | endopeptidase activity | 1.73e-03 | 430 | 103 | 8 | GO:0004175 | |
| GeneOntologyMolecularFunction | UDP-glucosyltransferase activity | 1.98e-03 | 13 | 103 | 2 | GO:0035251 | |
| GeneOntologyBiologicalProcess | entry of viral genome into host nucleus through nuclear pore complex via importin | 2.62e-05 | 2 | 106 | 2 | GO:0075506 | |
| GeneOntologyBiologicalProcess | negative regulation of axon extension | 4.25e-05 | 38 | 106 | 4 | GO:0030517 | |
| GeneOntologyBiologicalProcess | epithelium development | FOXN1 COL5A1 HGF PDGFRA CASP8 CRHR1 TMEFF2 MST1 TFCP2L1 SERPINE2 NKX6-3 DLC1 MIB1 PKD2 KCNQ1 ASTN2 MST1L DMBT1 MMP9 USH2A | 5.21e-05 | 1469 | 106 | 20 | GO:0060429 |
| GeneOntologyBiologicalProcess | morphogenesis of an epithelium | FOXN1 COL5A1 HGF PDGFRA CASP8 TMEFF2 MST1 DLC1 MIB1 PKD2 ASTN2 MST1L | 8.08e-05 | 619 | 106 | 12 | GO:0002009 |
| GeneOntologyBiologicalProcess | regulation of nervous system development | TRIM46 SEMA6C SEMA3F HGF ELAPOR2 ADGRB3 BCAN DCT TG SERPINE2 SRPX2 SEMA6D | 8.85e-05 | 625 | 106 | 12 | GO:0051960 |
| GeneOntologyBiologicalProcess | negative chemotaxis | 1.37e-04 | 51 | 106 | 4 | GO:0050919 | |
| GeneOntologyBiologicalProcess | negative regulation of immunoglobulin production | 1.41e-04 | 20 | 106 | 3 | GO:0002638 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 1.48e-04 | 52 | 106 | 4 | GO:0071526 | |
| GeneOntologyBiologicalProcess | viral penetration into host nucleus | 1.56e-04 | 4 | 106 | 2 | GO:0075732 | |
| GeneOntologyBiologicalProcess | negative regulation of cation channel activity | 1.97e-04 | 56 | 106 | 4 | GO:2001258 | |
| GeneOntologyBiologicalProcess | positive regulation of cAMP-mediated signaling | 2.17e-04 | 23 | 106 | 3 | GO:0043950 | |
| GeneOntologyBiologicalProcess | negative regulation of neuron projection development | 2.40e-04 | 169 | 106 | 6 | GO:0010977 | |
| GeneOntologyBiologicalProcess | transport of virus | 2.47e-04 | 24 | 106 | 3 | GO:0046794 | |
| GeneOntologyBiologicalProcess | regulation of cell motility | SEMA6C SEMA3F HGF PDGFRA CASP8 GRIN1 PRAG1 TMEFF2 ARF6 MST1 SEMA3D SERPINE2 SRPX2 DLC1 SEMA6D MST1L MMP9 | 2.75e-04 | 1280 | 106 | 17 | GO:2000145 |
| GeneOntologyBiologicalProcess | negative regulation of axonogenesis | 2.92e-04 | 62 | 106 | 4 | GO:0050771 | |
| GeneOntologyBiologicalProcess | neural crest cell migration | 2.92e-04 | 62 | 106 | 4 | GO:0001755 | |
| GeneOntologyBiologicalProcess | mesenchymal cell migration | 3.30e-04 | 64 | 106 | 4 | GO:0090497 | |
| GeneOntologyCellularComponent | extracellular matrix | COL4A5 COL5A1 COL11A2 BCAN CPN2 CHI3L1 MST1 EYS SERPINE2 SRPX2 SEMA6D DMBT1 MMP9 MMP17 USH2A MUC5AC FBN3 | 3.28e-08 | 656 | 106 | 17 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | COL4A5 COL5A1 COL11A2 BCAN CPN2 CHI3L1 MST1 EYS SERPINE2 SRPX2 SEMA6D DMBT1 MMP9 MMP17 USH2A MUC5AC FBN3 | 3.43e-08 | 658 | 106 | 17 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | COL4A5 COL5A1 COL11A2 BCAN CPN2 MST1 EYS SERPINE2 SRPX2 SEMA6D DMBT1 MMP9 USH2A | 2.86e-06 | 530 | 106 | 13 | GO:0062023 |
| GeneOntologyCellularComponent | cell surface | TSPAN15 SEMA6C LILRA1 PDGFRA BCAN GRIN1 CR1 SRPX2 CD5 SEMA6D CD22 UMODL1 FCGRT PEBP1 PVR CNTNAP2 LY75 | 4.22e-05 | 1111 | 106 | 17 | GO:0009986 |
| GeneOntologyCellularComponent | side of membrane | LILRA1 EPM2A PDGFRA BCAN CR1 CD5 CD22 UMODL1 FCGRT DPEP2 PKD2 KCNQ1 LY75 MMP17 | 1.35e-04 | 875 | 106 | 14 | GO:0098552 |
| GeneOntologyCellularComponent | complex of collagen trimers | 1.58e-04 | 21 | 106 | 3 | GO:0098644 | |
| GeneOntologyCellularComponent | collagen type XI trimer | 2.52e-04 | 5 | 106 | 2 | GO:0005592 | |
| GeneOntologyCellularComponent | axon initial segment | 4.21e-04 | 29 | 106 | 3 | GO:0043194 | |
| GeneOntologyCellularComponent | neuron projection membrane | 8.06e-04 | 82 | 106 | 4 | GO:0032589 | |
| GeneOntologyCellularComponent | host cell | 8.96e-04 | 9 | 106 | 2 | GO:0043657 | |
| GeneOntologyCellularComponent | NLS-dependent protein nuclear import complex | 1.12e-03 | 10 | 106 | 2 | GO:0042564 | |
| GeneOntologyCellularComponent | ionotropic glutamate receptor complex | 1.54e-03 | 45 | 106 | 3 | GO:0008328 | |
| GeneOntologyCellularComponent | nucleocytoplasmic transport complex | 1.63e-03 | 12 | 106 | 2 | GO:0031074 | |
| GeneOntologyCellularComponent | fibrillar collagen trimer | 1.63e-03 | 12 | 106 | 2 | GO:0005583 | |
| GeneOntologyCellularComponent | banded collagen fibril | 1.63e-03 | 12 | 106 | 2 | GO:0098643 | |
| GeneOntologyCellularComponent | neurotransmitter receptor complex | 2.09e-03 | 50 | 106 | 3 | GO:0098878 | |
| GeneOntologyCellularComponent | excitatory synapse | 2.16e-03 | 107 | 106 | 4 | GO:0060076 | |
| GeneOntologyCellularComponent | host cellular component | 2.56e-03 | 15 | 106 | 2 | GO:0018995 | |
| GeneOntologyCellularComponent | cell body | EPM2A CASP8 GRIN1 VPS16 CRHR1 SERPINE2 CD22 PEBP1 CNTNAP2 KCNQ1 ASTN2 USH2A | 2.62e-03 | 929 | 106 | 12 | GO:0044297 |
| GeneOntologyCellularComponent | asymmetric synapse | 2.97e-03 | 477 | 106 | 8 | GO:0032279 | |
| MousePheno | decreased immunoglobulin level | FOXN1 MAP4K3 SIGLEC16 IRF4 CHI3L1 TG CD22 FCGRT PVR SIGLEC1 MMP9 | 2.74e-06 | 315 | 84 | 11 | MP:0002460 |
| Domain | - | TRIM46 SEMA3F LILRA1 EPM2A PDGFRA BCAN NCR3LG1 SEMA3D FNDC7 CD22 UMODL1 FCGRT PVR ASTN2 SIGLEC1 USH2A | 7.71e-07 | 663 | 104 | 16 | 2.60.40.10 |
| Domain | Kringle-like | 8.68e-07 | 32 | 104 | 5 | IPR013806 | |
| Domain | PAN_AP | 1.66e-06 | 5 | 104 | 3 | SM00473 | |
| Domain | Ig-like_fold | TRIM46 SEMA3F LILRA1 EPM2A PDGFRA BCAN NCR3LG1 SEMA3D FNDC7 CD22 UMODL1 FCGRT PVR ASTN2 SIGLEC1 USH2A | 1.75e-06 | 706 | 104 | 16 | IPR013783 |
| Domain | Laminin_G_2 | 2.74e-06 | 40 | 104 | 5 | PF02210 | |
| Domain | Semaphorin | 4.10e-06 | 20 | 104 | 4 | IPR027231 | |
| Domain | LamG | 4.44e-06 | 44 | 104 | 5 | SM00282 | |
| Domain | Pan_app | 5.78e-06 | 7 | 104 | 3 | IPR003609 | |
| Domain | PAN | 5.78e-06 | 7 | 104 | 3 | PS50948 | |
| Domain | PAN_1 | 5.78e-06 | 7 | 104 | 3 | PF00024 | |
| Domain | EGF_1 | 1.27e-05 | 255 | 104 | 9 | PS00022 | |
| Domain | Laminin_G | 1.76e-05 | 58 | 104 | 5 | IPR001791 | |
| Domain | Semap_dom | 2.54e-05 | 31 | 104 | 4 | IPR001627 | |
| Domain | SEMA | 2.54e-05 | 31 | 104 | 4 | PS51004 | |
| Domain | Sema | 2.54e-05 | 31 | 104 | 4 | SM00630 | |
| Domain | Sema | 2.54e-05 | 31 | 104 | 4 | PF01403 | |
| Domain | HGF-like | 3.07e-05 | 2 | 104 | 2 | IPR024174 | |
| Domain | EGF_3 | 5.09e-05 | 235 | 104 | 8 | PS50026 | |
| Domain | LAM_G_DOMAIN | 5.79e-05 | 38 | 104 | 4 | PS50025 | |
| Domain | EGF | 7.40e-05 | 126 | 104 | 6 | PF00008 | |
| Domain | PSI | 1.04e-04 | 44 | 104 | 4 | IPR016201 | |
| Domain | Kringle_CS | 1.08e-04 | 17 | 104 | 3 | IPR018056 | |
| Domain | KRINGLE_1 | 1.08e-04 | 17 | 104 | 3 | PS00021 | |
| Domain | KR | 1.08e-04 | 17 | 104 | 3 | SM00130 | |
| Domain | Kringle | 1.08e-04 | 17 | 104 | 3 | IPR000001 | |
| Domain | KRINGLE_2 | 1.08e-04 | 17 | 104 | 3 | PS50070 | |
| Domain | Kringle | 1.08e-04 | 17 | 104 | 3 | PF00051 | |
| Domain | EGF_2 | 1.18e-04 | 265 | 104 | 8 | PS01186 | |
| Domain | PSI | 1.24e-04 | 46 | 104 | 4 | SM00423 | |
| Domain | - | 1.89e-04 | 95 | 104 | 5 | 2.60.120.200 | |
| Domain | EGF | 3.45e-04 | 235 | 104 | 7 | SM00181 | |
| Domain | HormR | 3.53e-04 | 25 | 104 | 3 | SM00008 | |
| Domain | IG_LIKE | SEMA3F LILRA1 PDGFRA BCAN NCR3LG1 SEMA3D CD22 FCGRT PVR SIGLEC1 | 4.13e-04 | 491 | 104 | 10 | PS50835 |
| Domain | EGF-like_dom | 4.87e-04 | 249 | 104 | 7 | IPR000742 | |
| Domain | HRM | 4.97e-04 | 28 | 104 | 3 | PF02793 | |
| Domain | Ig-like_dom | SEMA3F LILRA1 PDGFRA BCAN NCR3LG1 SEMA3D CD22 FCGRT PVR SIGLEC1 | 4.98e-04 | 503 | 104 | 10 | IPR007110 |
| Domain | Peptidase_Metallo | 5.52e-04 | 29 | 104 | 3 | IPR006026 | |
| Domain | ZnMc | 5.52e-04 | 29 | 104 | 3 | SM00235 | |
| Domain | IG | 5.73e-04 | 421 | 104 | 9 | SM00409 | |
| Domain | Ig_sub | 5.73e-04 | 421 | 104 | 9 | IPR003599 | |
| Domain | Arm_3 | 6.33e-04 | 7 | 104 | 2 | PF16186 | |
| Domain | Importing_su_alpha | 6.33e-04 | 7 | 104 | 2 | IPR024931 | |
| Domain | IBB | 6.33e-04 | 7 | 104 | 2 | PF01749 | |
| Domain | Arm_3 | 6.33e-04 | 7 | 104 | 2 | IPR032413 | |
| Domain | EGF-like_CS | 6.44e-04 | 261 | 104 | 7 | IPR013032 | |
| Domain | ig | 6.81e-04 | 190 | 104 | 6 | PF00047 | |
| Domain | Immunoglobulin | 6.81e-04 | 190 | 104 | 6 | IPR013151 | |
| Domain | Plexin_repeat | 7.40e-04 | 32 | 104 | 3 | IPR002165 | |
| Domain | PSI | 7.40e-04 | 32 | 104 | 3 | PF01437 | |
| Domain | IBB | 8.41e-04 | 8 | 104 | 2 | PS51214 | |
| Domain | GPCR_2_secretin-like_CS | 8.85e-04 | 34 | 104 | 3 | IPR017983 | |
| Domain | Importin-a_IBB | 1.08e-03 | 9 | 104 | 2 | IPR002652 | |
| Domain | ConA-like_dom | 1.42e-03 | 219 | 104 | 6 | IPR013320 | |
| Domain | GPCR_2_extracellular_dom | 1.43e-03 | 40 | 104 | 3 | IPR001879 | |
| Domain | G_PROTEIN_RECEP_F2_1 | 1.43e-03 | 40 | 104 | 3 | PS00649 | |
| Domain | G_PROTEIN_RECEP_F2_3 | 1.43e-03 | 40 | 104 | 3 | PS50227 | |
| Domain | C2-set_2 | 1.53e-03 | 41 | 104 | 3 | PF08205 | |
| Domain | CD80_C2-set | 1.53e-03 | 41 | 104 | 3 | IPR013162 | |
| Domain | NC1_FIB | 1.63e-03 | 11 | 104 | 2 | PS51461 | |
| Domain | Fib_collagen_C | 1.63e-03 | 11 | 104 | 2 | PD002078 | |
| Domain | Fib_collagen_C | 1.63e-03 | 11 | 104 | 2 | IPR000885 | |
| Domain | COLFI | 1.63e-03 | 11 | 104 | 2 | PF01410 | |
| Domain | COLFI | 1.63e-03 | 11 | 104 | 2 | SM00038 | |
| Domain | Growth_fac_rcpt_ | 1.80e-03 | 156 | 104 | 5 | IPR009030 | |
| Domain | EGF_Ca-bd_CS | 2.11e-03 | 97 | 104 | 4 | IPR018097 | |
| Domain | ZINC_PROTEASE | 2.19e-03 | 98 | 104 | 4 | PS00142 | |
| Domain | EGF_CA | 2.28e-03 | 99 | 104 | 4 | PS01187 | |
| Domain | FN_type2_col-bd | 2.68e-03 | 14 | 104 | 2 | IPR000562 | |
| Domain | FN2_2 | 2.68e-03 | 14 | 104 | 2 | PS51092 | |
| Domain | ZP_2 | 2.68e-03 | 14 | 104 | 2 | PS51034 | |
| Domain | FN2_1 | 2.68e-03 | 14 | 104 | 2 | PS00023 | |
| Domain | ZP_1 | 2.68e-03 | 14 | 104 | 2 | PS00682 | |
| Domain | fn2 | 2.68e-03 | 14 | 104 | 2 | PF00040 | |
| Domain | FN2 | 2.68e-03 | 14 | 104 | 2 | SM00059 | |
| Domain | 7tm_2 | 2.72e-03 | 50 | 104 | 3 | PF00002 | |
| Domain | G_PROTEIN_RECEP_F2_2 | 2.72e-03 | 50 | 104 | 3 | PS00650 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 2.92e-03 | 106 | 104 | 4 | IPR000152 | |
| Domain | CTDL_fold | 3.02e-03 | 107 | 104 | 4 | IPR016187 | |
| Domain | Sushi | 3.04e-03 | 52 | 104 | 3 | PF00084 | |
| Domain | ZP | 3.08e-03 | 15 | 104 | 2 | SM00241 | |
| Domain | CUB | 3.21e-03 | 53 | 104 | 3 | PS01180 | |
| Domain | CCP | 3.39e-03 | 54 | 104 | 3 | SM00032 | |
| Domain | SUSHI | 3.75e-03 | 56 | 104 | 3 | PS50923 | |
| Domain | FN3 | 3.77e-03 | 185 | 104 | 5 | SM00060 | |
| Domain | Sushi_SCR_CCP_dom | 3.95e-03 | 57 | 104 | 3 | IPR000436 | |
| Domain | CUB_dom | 3.95e-03 | 57 | 104 | 3 | IPR000859 | |
| Domain | ZP_dom | 3.95e-03 | 17 | 104 | 2 | IPR001507 | |
| Domain | Zona_pellucida | 3.95e-03 | 17 | 104 | 2 | PF00100 | |
| Domain | Ig/MHC_CS | 4.14e-03 | 58 | 104 | 3 | IPR003006 | |
| Domain | IG_MHC | 4.56e-03 | 60 | 104 | 3 | PS00290 | |
| Domain | GPCR_2_secretin-like | 4.56e-03 | 60 | 104 | 3 | IPR000832 | |
| Domain | GPCR_2-like | 4.56e-03 | 60 | 104 | 3 | IPR017981 | |
| Domain | G_PROTEIN_RECEP_F2_4 | 4.78e-03 | 61 | 104 | 3 | PS50261 | |
| Domain | EGF_CA | 4.82e-03 | 122 | 104 | 4 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 5.11e-03 | 124 | 104 | 4 | IPR001881 | |
| Domain | FN3 | 5.13e-03 | 199 | 104 | 5 | PS50853 | |
| Domain | PG_binding_1 | 5.47e-03 | 20 | 104 | 2 | PF01471 | |
| Domain | Peptidoglycan-bd-like | 5.47e-03 | 20 | 104 | 2 | IPR002477 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 1.12e-06 | 140 | 79 | 8 | M587 | |
| Pathway | PID_SYNDECAN_1_PATHWAY | 5.57e-06 | 46 | 79 | 5 | M198 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 8.46e-06 | 50 | 79 | 5 | MM14796 | |
| Pathway | REACTOME_ASSEMBLY_OF_COLLAGEN_FIBRILS_AND_OTHER_MULTIMERIC_STRUCTURES | 2.26e-05 | 61 | 79 | 5 | M27103 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 4.21e-05 | 114 | 79 | 6 | MM14571 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 6.58e-05 | 76 | 79 | 5 | MM14573 | |
| Pathway | REACTOME_COLLAGEN_FORMATION | 1.47e-04 | 90 | 79 | 5 | M631 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 1.54e-04 | 19 | 79 | 3 | MM15512 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 2.17e-04 | 53 | 79 | 4 | MM14566 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.70e-04 | 300 | 79 | 8 | M610 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 3.74e-04 | 61 | 79 | 4 | MM14637 | |
| Pathway | REACTOME_COLLAGEN_DEGRADATION | 4.50e-04 | 64 | 79 | 4 | M26953 | |
| Pathway | REACTOME_SIGNALING_BY_MST1 | 4.58e-04 | 6 | 79 | 2 | MM15492 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 5.33e-04 | 418 | 79 | 9 | MM15587 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 5.36e-04 | 67 | 79 | 4 | MM15345 | |
| Pathway | REACTOME_COLLAGEN_BIOSYNTHESIS_AND_MODIFYING_ENZYMES | 5.36e-04 | 67 | 79 | 4 | M26999 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 5.98e-04 | 258 | 79 | 7 | MM14572 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 6.17e-04 | 30 | 79 | 3 | M27772 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 6.17e-04 | 30 | 79 | 3 | MM15517 | |
| Pathway | BIOCARTA_MSP_PATHWAY | 6.39e-04 | 7 | 79 | 2 | MM1580 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 7.47e-04 | 32 | 79 | 3 | MM14924 | |
| Pathway | PID_AVB3_INTEGRIN_PATHWAY | 7.81e-04 | 74 | 79 | 4 | M160 | |
| Pathway | WP_MIR302367_PROMOTING_CARDIOMYOCYTE_PROLIFERATION | 8.49e-04 | 8 | 79 | 2 | MM15986 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 9.98e-04 | 79 | 79 | 4 | M27643 | |
| Pathway | REACTOME_MYOCLONIC_EPILEPSY_OF_LAFORA | 1.09e-03 | 9 | 79 | 2 | M27276 | |
| Pathway | REACTOME_MET_RECEPTOR_RECYCLING | 1.36e-03 | 10 | 79 | 2 | M27777 | |
| Pathway | WP_MAMMARY_GLAND_DEVELOPMENT_INVOLUTION_STAGE_4_OF_4 | 1.36e-03 | 10 | 79 | 2 | M39534 | |
| Pathway | REACTOME_MET_RECEPTOR_RECYCLING | 1.36e-03 | 10 | 79 | 2 | MM15516 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.55e-03 | 41 | 79 | 3 | M27778 | |
| Pathway | REACTOME_COLLAGEN_CHAIN_TRIMERIZATION | 1.55e-03 | 41 | 79 | 3 | MM15538 | |
| Pubmed | 7.70e-06 | 13 | 106 | 3 | 27488639 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 7925291 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17020973 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 8393443 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 27609031 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24980820 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17585360 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19501047 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 10728827 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 16961763 | ||
| Pubmed | Inhibiting endothelial cell Mst1 attenuates acute lung injury in mice. | 9.20e-06 | 2 | 106 | 2 | 39253972 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 32017081 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 24409221 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 21061433 | ||
| Pubmed | Hepatocyte-specific expression of the mouse hepatocyte growth factor-like protein. | 9.20e-06 | 2 | 106 | 2 | 8340069 | |
| Pubmed | Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice. | 9.20e-06 | 2 | 106 | 2 | 9486989 | |
| Pubmed | Treatment with XMU-MP-1 erases hyperglycaemic memory in hearts of diabetic mice. | 9.20e-06 | 2 | 106 | 2 | 33887258 | |
| Pubmed | Glycogen metabolism in tissues from a mouse model of Lafora disease. | 9.20e-06 | 2 | 106 | 2 | 17118331 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25938541 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25704757 | ||
| Pubmed | Mst1 regulates post-infarction cardiac injury through the JNK-Drp1-mitochondrial fission pathway. | 9.20e-06 | 2 | 106 | 2 | 29760744 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 18567713 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 19494703 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 17592270 | ||
| Pubmed | ANKS1B is a smoking-related molecular alteration in clear cell renal cell carcinoma. | 9.20e-06 | 2 | 106 | 2 | 24479813 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 31206688 | ||
| Pubmed | Inhibiting glycogen synthesis prevents Lafora disease in a mouse model. | 9.20e-06 | 2 | 106 | 2 | 23913475 | |
| Pubmed | Siglec-1 and -2 as potential biomarkers in autoimmune disease. | 9.20e-06 | 2 | 106 | 2 | 26752092 | |
| Pubmed | Metalloproteinases mediate mucin 5AC expression by epidermal growth factor receptor activation. | 9.20e-06 | 2 | 106 | 2 | 15531749 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 12110693 | ||
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 25659756 | ||
| Pubmed | Mst1 inhibition attenuates non-alcoholic fatty liver disease via reversing Parkin-related mitophagy. | 9.20e-06 | 2 | 106 | 2 | 30708325 | |
| Pubmed | 9.20e-06 | 2 | 106 | 2 | 28371152 | ||
| Pubmed | YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma. | 9.20e-06 | 2 | 106 | 2 | 21391238 | |
| Pubmed | Melatonin alleviates postinfarction cardiac remodeling and dysfunction by inhibiting Mst1. | 9.20e-06 | 2 | 106 | 2 | 27696525 | |
| Pubmed | Human-like PB2 627K influenza virus polymerase activity is regulated by importin-α1 and -α7. | 9.20e-06 | 2 | 106 | 2 | 22275867 | |
| Pubmed | 1.29e-05 | 167 | 106 | 6 | 22159717 | ||
| Pubmed | 1.50e-05 | 16 | 106 | 3 | 22632726 | ||
| Pubmed | 1.97e-05 | 52 | 106 | 4 | 26633812 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 14676276 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 16469801 | ||
| Pubmed | The Ron/STK receptor tyrosine kinase is essential for peri-implantation development in the mouse. | 2.76e-05 | 3 | 106 | 2 | 10225971 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 38430683 | ||
| Pubmed | TRAF2 functions as an activator switch in the reactive oxygen species-induced stimulation of MST1. | 2.76e-05 | 3 | 106 | 2 | 26698664 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 21539913 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17395874 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 23933820 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 37192383 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 28429746 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 28189564 | ||
| Pubmed | Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. | 2.76e-05 | 3 | 106 | 2 | 18006877 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 27496379 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 12606483 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 30404949 | ||
| Pubmed | HUNK inhibits cargo uptake and lysosomal traffic in the caveolar pathway via the AGAP3/ARF6. | 2.76e-05 | 3 | 106 | 2 | 38071109 | |
| Pubmed | Mst1-mediated phosphorylation of Nur77 improves the endometrial receptivity in human and mice. | 2.76e-05 | 3 | 106 | 2 | 36623453 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 31392351 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 38288506 | ||
| Pubmed | The proto-oncogene RON is involved in development of epithelial, bone and neuro-endocrine tissues. | 2.76e-05 | 3 | 106 | 2 | 8545120 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 25049204 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 1832957 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 25183307 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 35525373 | ||
| Pubmed | MST1 coordinately regulates autophagy and apoptosis in diabetic cardiomyopathy in mice. | 2.76e-05 | 3 | 106 | 2 | 27510910 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 37913847 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 17010584 | ||
| Pubmed | Identification of neutrophil activation markers as novel surrogate markers of CF lung disease. | 2.76e-05 | 3 | 106 | 2 | 25545245 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 7533044 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 22578008 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 38898027 | ||
| Pubmed | WASP and Mst1 coregulate B-cell development and B-cell receptor signaling. | 2.76e-05 | 3 | 106 | 2 | 32045478 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 24099107 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 27940445 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 36553626 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 32214200 | ||
| Pubmed | Sema6B, Sema6C, and Sema6D expression and function during mammalian retinal development. | 2.76e-05 | 3 | 106 | 2 | 23646199 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 12538524 | ||
| Pubmed | Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes. | 2.76e-05 | 3 | 106 | 2 | 19339990 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 12837293 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 1334458 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 19710364 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 30063115 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 34526107 | ||
| Pubmed | Mst1-mediated phosphorylation of Bcl-xL is required for myocardial reperfusion injury. | 2.76e-05 | 3 | 106 | 2 | 27218122 | |
| Pubmed | Genetic deletion of Mst1 alters T cell function and protects against autoimmunity. | 2.76e-05 | 3 | 106 | 2 | 24852423 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 34009784 | ||
| Pubmed | CD147 increases mucus secretion induced by cigarette smoke in COPD. | 2.76e-05 | 3 | 106 | 2 | 30727993 | |
| Pubmed | IFR4/MUM1-positive lymphoma in Waldeyer ring with co-expression of CD5 and CD10. | 2.76e-05 | 3 | 106 | 2 | 27616053 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 12804176 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 37184367 | ||
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 31976559 | ||
| Pubmed | Over-expressed MST1 impaired spatial memory via disturbing neural oscillation patterns in mice. | 2.76e-05 | 3 | 106 | 2 | 32468668 | |
| Pubmed | Nicorandil alleviates myocardial injury and post-infarction cardiac remodeling by inhibiting Mst1. | 2.76e-05 | 3 | 106 | 2 | 29127009 | |
| Pubmed | Mst1 Kinase Regulates the Actin-Bundling Protein L-Plastin To Promote T Cell Migration. | 2.76e-05 | 3 | 106 | 2 | 27465533 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 30771091 | ||
| Pubmed | MST1 mediates the N-methyl-D-aspartate-induced excitotoxicity in mouse cortical neurons. | 2.76e-05 | 3 | 106 | 2 | 34967918 | |
| Pubmed | 2.76e-05 | 3 | 106 | 2 | 31940496 | ||
| Pubmed | 3.06e-05 | 117 | 106 | 5 | 17145500 | ||
| Pubmed | Motor neurons use push-pull signals to direct vascular remodeling critical for their connectivity. | 3.52e-05 | 21 | 106 | 3 | 36240771 | |
| Pubmed | 3.52e-05 | 21 | 106 | 3 | 22072979 | ||
| GeneFamily | Immunoglobulin like domain containing|Semaphorins | 1.01e-06 | 20 | 71 | 4 | 736 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.79e-05 | 40 | 71 | 4 | 592 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 2.28e-05 | 394 | 71 | 9 | 471 | |
| GeneFamily | CD molecules|C2-set domain containing|Sialic acid binding Ig like lectins | 1.77e-04 | 28 | 71 | 3 | 745 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 4.51e-04 | 163 | 71 | 5 | 590 | |
| GeneFamily | Collagens | 7.80e-04 | 46 | 71 | 3 | 490 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.46e-03 | 57 | 71 | 3 | 1179 | |
| GeneFamily | Armadillo repeat containing|Importins | 2.23e-03 | 18 | 71 | 2 | 596 | |
| GeneFamily | Endogenous ligands|Matrix metallopeptidases | 3.97e-03 | 24 | 71 | 2 | 891 | |
| Coexpression | NABA_MATRISOME | SEMA6C SEMA3F COL4A5 COL5A1 HGF COL11A2 BCAN CPN2 MST1 SEMA3D EYS FNDC7 SERPINE2 SRPX2 SEMA6D CLEC2L TLL2 MST1L DMBT1 MMP9 MMP17 USH2A MUC5AC FBN3 | 2.34e-12 | 1026 | 106 | 24 | M5889 |
| Coexpression | NABA_MATRISOME | SEMA6C SEMA3F COL4A5 COL5A1 HGF COL11A2 BCAN CPN2 MST1 SEMA3D FNDC7 SERPINE2 SRPX2 SEMA6D CLEC2L TLL2 MST1L DMBT1 MMP9 MMP17 MUC5AC | 5.60e-10 | 1008 | 106 | 21 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | 1.80e-07 | 275 | 106 | 10 | M5884 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | SEMA6C SEMA3F HGF CPN2 MST1 SEMA3D SERPINE2 SEMA6D CLEC2L TLL2 MST1L MMP9 MMP17 MUC5AC | 1.68e-06 | 738 | 106 | 14 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | SEMA6C SEMA3F HGF CPN2 MST1 SEMA3D SERPINE2 SEMA6D CLEC2L TLL2 MST1L MMP9 MMP17 MUC5AC | 2.06e-06 | 751 | 106 | 14 | M5885 |
| Coexpression | ROESSLER_LIVER_CANCER_METASTASIS_UP | 4.66e-06 | 106 | 106 | 6 | M2544 | |
| Coexpression | IWANAGA_CARCINOGENESIS_BY_KRAS_PTEN_UP | 2.39e-05 | 210 | 106 | 7 | MM751 | |
| Coexpression | NABA_ECM_AFFILIATED | 4.53e-05 | 158 | 106 | 6 | MM17063 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | SEMA6C HGF LILRA1 CHI3L1 CR1 TFCP2L1 FCGRT DPEP2 KCNQ1 TDRD6 MMP9 SHISA8 | 4.57e-05 | 740 | 106 | 12 | M41202 |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_MELANOMA | 5.02e-05 | 18 | 106 | 3 | M47984 | |
| Coexpression | NABA_ECM_AFFILIATED | 6.80e-05 | 170 | 106 | 6 | M5880 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.17e-09 | 198 | 106 | 9 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-08 | 185 | 106 | 8 | f814ec9d4ade717a0109398e9768d0d66f09317b | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-08 | 185 | 106 | 8 | 40e958511790e84321da5ccf735f9974c06a0263 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.50e-08 | 185 | 106 | 8 | 5f2eeba80aff145e85cfd81e2890a155406badb9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.35e-08 | 196 | 106 | 8 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.65e-08 | 199 | 106 | 8 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.53e-07 | 167 | 106 | 7 | 83969c36ac44b96afc9aa09400a99fa2b487f7ff | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-07 | 180 | 106 | 7 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.55e-07 | 180 | 106 | 7 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-07 | 181 | 106 | 7 | c6d2a13df3b74fade3b0c71e285b4c14c8e52413 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.64e-07 | 181 | 106 | 7 | c62b0a2422377ffadaab63edd538e87a06fa5017 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.75e-07 | 182 | 106 | 7 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.80e-07 | 191 | 106 | 7 | b7a57691a4742070cee640e285c1f4d0da95baf1 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.94e-07 | 192 | 106 | 7 | 4022f208eb5db760abd0aac782a25e8ab63efc64 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-07 | 192 | 106 | 7 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-07 | 192 | 106 | 7 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.08e-07 | 193 | 106 | 7 | fb28717fadd06c3840636d25409ce80c9254bd34 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.23e-07 | 194 | 106 | 7 | 99577a5a631e607b5abe7a1b0d8d6a5eabe50196 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.23e-07 | 194 | 106 | 7 | 8c37bedb23285735ff3828db3889897fada8c95d | |
| ToppCell | COVID-19-Heart-Fib_1|Heart / Disease (COVID-19 only), tissue and cell type | 4.37e-07 | 195 | 106 | 7 | f423baa36ac7cdc383c033e35a7d17e6bf913323 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.37e-07 | 195 | 106 | 7 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | 10x5'v1-week_17-19-Mesenchymal_osteo-stroma-osteoblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.53e-07 | 196 | 106 | 7 | d5ed41fa111750e6b363c04cccc40a47dd774852 | |
| ToppCell | PCW_13-14-Mesenchymal|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.69e-07 | 197 | 106 | 7 | 73a2085d2682d636726a5432d572ae2a3fbe1c3f | |
| ToppCell | PCW_10-12|World / Celltypes from embryonic and fetal-stage human lung | 4.69e-07 | 197 | 106 | 7 | 47fd8b0d596c5db1a722473c8efbb17a6bbe7538 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.69e-07 | 197 | 106 | 7 | 6668f0da54f3bf96769275e668cd57e00b8a5ef9 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.69e-07 | 197 | 106 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.69e-07 | 197 | 106 | 7 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.85e-07 | 198 | 106 | 7 | 9541d68a1a6247dbd7161a62644eea6527c2c8ff | |
| ToppCell | wk_08-11-Mesenchymal-Fibroblast-intermediate_fibro|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 5.01e-07 | 199 | 106 | 7 | f9e3fb974ba8fe1b6d99892577549ef143df9e08 | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.19e-07 | 200 | 106 | 7 | b7b9441fa7ab0d43741a2ebd5ec1a48d537c6d47 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.19e-07 | 200 | 106 | 7 | 4f624c3c57d1a84baa86d0830cb1b83ae110bf67 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast-intermediate_fibro|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.19e-07 | 200 | 106 | 7 | 6461d25fd8fb52921b188f083fbe808535d3130b | |
| ToppCell | Bronchial-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.19e-07 | 200 | 106 | 7 | 7c673ad0ea503ebd196579684d25d5f9e6a41030 | |
| ToppCell | Substantia_nigra-Macroglia-POLYDENDROCYTE|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 1.61e-06 | 150 | 106 | 6 | 70ac8ae4b1683fb17278a8e4606f2fa0b94988c0 | |
| ToppCell | COVID-19-lung-Mesothelial|lung / Disease (COVID-19 only), tissue and cell type | 2.02e-06 | 156 | 106 | 6 | e1f563869b3bf997eaa2e756e31b53db1a478903 | |
| ToppCell | COVID-19-Heart-Neuronal|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.10e-06 | 168 | 106 | 6 | 88c2c574f428c2502b5fe099bd73b0758f668ef6 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-ENCC/glia_Progenitor|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.10e-06 | 168 | 106 | 6 | 948d9e9972bd2a4b503d55fa69b70dd568a35a67 | |
| ToppCell | facs-Marrow-B-cells-24m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.93e-06 | 175 | 106 | 6 | 887e75fc90e59a6394d62f3c048a9cfdf6707725 | |
| ToppCell | NS-moderate-d_07-13-Lymphoid-NK|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.93e-06 | 175 | 106 | 6 | f6cd24d22f62469319f9d244e3e5de527d3d4d94 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-06 | 176 | 106 | 6 | b4a23d8d1414434adeb237a96f28c825f1aebd77 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.06e-06 | 176 | 106 | 6 | 66c9c6b59030f67e8d746a9c6930e50923f2ded1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma-6|TCGA-Ovary / Sample_Type by Project: Shred V9 | 4.33e-06 | 178 | 106 | 6 | 142879e9393e721f9b05a6bb46995c9d6d713c95 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.33e-06 | 178 | 106 | 6 | 78a0c6340001a77f5b2d890b6263f574af2e72da | |
| ToppCell | 10x5'v1-week_12-13-Lymphocytic_NK-T_NK-ILC_precursor|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 4.47e-06 | 179 | 106 | 6 | bc95c3e7edc5fc6fc913b09f087d221df64c6f48 | |
| ToppCell | PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.47e-06 | 179 | 106 | 6 | ff678e2f33c914e3dd0f338ada25f506c3e3c980 | |
| ToppCell | droplet-Bladder-nan-24m-Epithelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-06 | 179 | 106 | 6 | 3d6bb3cfe89d60f2f00aead9341f9967e5313763 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Erythrocytic-Meg|bone_marrow / Manually curated celltypes from each tissue | 4.62e-06 | 180 | 106 | 6 | 44ba37bead1ac39bce4d3eef00961063c50ced0d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.92e-06 | 182 | 106 | 6 | 3dfa9187e9d2bab1d199079d29209c4648220ada | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.24e-06 | 184 | 106 | 6 | 3bffadb0cb2e0d825bdb6cfc5d23f5436cbc3efd | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-06 | 185 | 106 | 6 | 33cc0e9d8b54cb7408b51235f2a70e044ebae04d | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 5.41e-06 | 185 | 106 | 6 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-Stroma____fibroblast|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.41e-06 | 185 | 106 | 6 | 9954fc85b183c1cc45c3c24e3dadc7984ee6f649 | |
| ToppCell | moderate-Lymphoid-NK|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.41e-06 | 185 | 106 | 6 | 4979a787acbc9b4ca8defe91cc79b674e51af1bf | |
| ToppCell | TCGA-Ovary-Primary_Tumor|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.54e-06 | 106 | 106 | 5 | 14f548be39cec604fbdae0382cbf434fa4049840 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.54e-06 | 106 | 106 | 5 | 939b80950d39cdc7149a05fdfb64c8810064cdb1 | |
| ToppCell | TCGA-Ovary-Primary_Tumor-Ovarian_Carcinoma-Serous_Cystadenocarcinoma|TCGA-Ovary / Sample_Type by Project: Shred V9 | 5.54e-06 | 106 | 106 | 5 | e9e1b55f32b3d5b9eeec94a997912e5c21c1fb48 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.57e-06 | 186 | 106 | 6 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | E16.5-samps-Mesenchymal-Myofibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 5.57e-06 | 186 | 106 | 6 | e044b3428b7eacfdc72d0f57cdabaa1de04c74cd | |
| ToppCell | normal_Lung-Myeloid_cells-Activated_DCs|Myeloid_cells / Location, Cell class and cell subclass | 5.57e-06 | 186 | 106 | 6 | 00ad1239b952119b3fd2e6af8f034cba3488f9c1 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-06 | 187 | 106 | 6 | 87b3d0478693d4c54ff06b74e5903036b9c1ee6a | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-06 | 187 | 106 | 6 | 42a1267bfc27b4460b8409ada580a87c4385841c | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 5.75e-06 | 187 | 106 | 6 | 64afdea159f5e67a1e5cea35ce898aae6e80aea5 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 5.75e-06 | 187 | 106 | 6 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | IPF-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 5.93e-06 | 188 | 106 | 6 | 5f5fad2773e421760e67dbace23fd1f847a2e1e0 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.93e-06 | 188 | 106 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-06 | 189 | 106 | 6 | 71397e993a77d70b2eeede240bdfc7660b558987 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.11e-06 | 189 | 106 | 6 | 4eea4759520c312bd17a681034d8074e47093d2b | |
| ToppCell | moderate-Lymphoid-NK|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.11e-06 | 189 | 106 | 6 | 22a19365782003c18ec8dddcdbfdaa82c4e330f6 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.11e-06 | 189 | 106 | 6 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | megakaryocytic-CD34+_Megakaryoblast|World / Lineage and Cell class | 6.30e-06 | 190 | 106 | 6 | 1d19b2bd55789bf13e1386332f46c605973d6f8e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-06 | 190 | 106 | 6 | 2306aa9dbeaef3be8484a5b236605de23cd75d4c | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.30e-06 | 190 | 106 | 6 | 7986586b7c82e91c71102cc8c4d7a689ae63ab4d | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.30e-06 | 190 | 106 | 6 | 1f83f7f24288a3b9ab33c2e113e845dba96adc8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-06 | 191 | 106 | 6 | a58c75e9580139fb370b498d95660f10f3a2a27b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-06 | 191 | 106 | 6 | 39092a0aff8097617820c59f5fea9ee2bb4f63a2 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro1_(4)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 6.49e-06 | 191 | 106 | 6 | fa380a8752de158974b2ae5e741573439719cc0d | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 6.49e-06 | 191 | 106 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 6.49e-06 | 191 | 106 | 6 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen+matrisome-high_fibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.49e-06 | 191 | 106 | 6 | ee5f1b1c59029c46cbb1a00935c03b9317bb9da9 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-06 | 192 | 106 | 6 | 9093a9e94a25682d109a7f6edc256a25a61103a0 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.69e-06 | 192 | 106 | 6 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-06 | 192 | 106 | 6 | bc84b9ce01b4d826a682842ab8a395dac9b91183 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-06 | 192 | 106 | 6 | 9ed5d49621ec1aa01716dc369bba1450b5f015f5 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 6.69e-06 | 192 | 106 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.69e-06 | 192 | 106 | 6 | 3d0cb19f037f604253d7d728689aeaa94251e92b | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-06 | 192 | 106 | 6 | 9333aba0d04203ccccad78d82bf6359922f810a7 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.69e-06 | 192 | 106 | 6 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Capillary_Aerocyte_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.69e-06 | 192 | 106 | 6 | f094ac378e635cf5820e8a8b7a0152073a51ceae | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.69e-06 | 192 | 106 | 6 | 0ab1176cfbb0de8dd1f22c6e2c41265cf6c10ee1 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 6.69e-06 | 192 | 106 | 6 | 8dc3016601148243196e925641c9507e9d58c9e0 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.89e-06 | 193 | 106 | 6 | f1199518c3626fd29bfce65070dd21a660671213 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.89e-06 | 193 | 106 | 6 | dc8e62df6121ee99b156aca6b1b3ae555739b6f2 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.89e-06 | 193 | 106 | 6 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.89e-06 | 193 | 106 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_119|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 6.89e-06 | 193 | 106 | 6 | e2ee077fd381bd906e6b4329f22e7d106e422a7f | |
| ToppCell | droplet-Lung-30m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_aerocyte_endothelial_cell|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.09e-06 | 194 | 106 | 6 | cf7f232827945fbafd2c298c08a799ab916c2472 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.09e-06 | 194 | 106 | 6 | 28c5482da199bcee9e85258a88af453d9fdbd56a | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-06 | 194 | 106 | 6 | 415801a3dfacf05f2b603fb424df3d045190a812 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_adventitial_fibro_(9)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 7.09e-06 | 194 | 106 | 6 | 5f5f0cdeacd5e1b28717d78dabdb9eb95f661e36 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.09e-06 | 194 | 106 | 6 | 256cb33ec90328f2704921fb0fe0fd9812e138b0 | |
| Drug | rhamnose | COL4A5 COL5A1 COL11A2 MAP4K3 BCAN TG CD22 FCGRT PVR MMP9 MUC5AC | 8.65e-07 | 356 | 106 | 11 | CID000000840 |
| Drug | Benfotiamine [22457-89-2]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 3.83e-06 | 196 | 106 | 8 | 3837_UP | |
| Drug | Methacycline hydrochloride [3963-95-9]; Up 200; 8.4uM; PC3; HT_HG-U133A | 4.13e-06 | 198 | 106 | 8 | 4062_UP | |
| Drug | Sn-8 | 8.07e-06 | 9 | 106 | 3 | CID000206458 | |
| Disease | Connective Tissue Diseases | 1.15e-05 | 13 | 103 | 3 | C0009782 | |
| Disease | gout | 6.66e-05 | 196 | 103 | 6 | EFO_0004274 | |
| Disease | retinitis pigmentosa (is_marker_for) | 7.21e-05 | 4 | 103 | 2 | DOID:10584 (is_marker_for) | |
| Disease | Lafora disease (implicated_via_orthology) | 7.21e-05 | 4 | 103 | 2 | DOID:3534 (implicated_via_orthology) | |
| Disease | diabetes mellitus | 9.60e-05 | 68 | 103 | 4 | EFO_0000400 | |
| Disease | family history of Alzheimer’s disease | 1.14e-04 | 71 | 103 | 4 | EFO_0009268 | |
| Disease | myocardial infarction (is_marker_for) | 2.09e-04 | 33 | 103 | 3 | DOID:5844 (is_marker_for) | |
| Disease | Autoimmune Lymphoproliferative Syndrome Type 2B | 2.51e-04 | 7 | 103 | 2 | C1846545 | |
| Disease | temporal arteritis (is_marker_for) | 2.51e-04 | 7 | 103 | 2 | DOID:13375 (is_marker_for) | |
| Disease | biliary tract benign neoplasm (is_marker_for) | 2.51e-04 | 7 | 103 | 2 | DOID:0050625 (is_marker_for) | |
| Disease | angle-closure glaucoma (is_implicated_in) | 2.51e-04 | 7 | 103 | 2 | DOID:13550 (is_implicated_in) | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 3.22e-04 | 93 | 103 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | cognitive disorder (biomarker_via_orthology) | 3.33e-04 | 8 | 103 | 2 | DOID:1561 (biomarker_via_orthology) | |
| Disease | sciatic neuropathy (biomarker_via_orthology) | 4.09e-04 | 99 | 103 | 4 | DOID:11446 (biomarker_via_orthology) | |
| Disease | retinal degeneration (is_implicated_in) | 4.28e-04 | 9 | 103 | 2 | DOID:8466 (is_implicated_in) | |
| Disease | pancreatic cancer (is_marker_for) | 4.41e-04 | 101 | 103 | 4 | DOID:1793 (is_marker_for) | |
| Disease | cognitive impairment measurement | 4.93e-04 | 44 | 103 | 3 | EFO_0007998 | |
| Disease | testosterone measurement | HGF NPEPPS ANKS1B DCT SEMA3D NALF1 SEMA6D FCGRT NYNRIN GYS1 CNTNAP2 USH2A KPNA2 | 4.98e-04 | 1275 | 103 | 13 | EFO_0004908 |
| Disease | cholesteatoma (is_marker_for) | 5.33e-04 | 10 | 103 | 2 | DOID:869 (is_marker_for) | |
| Disease | interstitial lung disease (is_implicated_in) | 5.33e-04 | 10 | 103 | 2 | DOID:3082 (is_implicated_in) | |
| Disease | polymyositis (is_marker_for) | 6.50e-04 | 11 | 103 | 2 | DOID:0080745 (is_marker_for) | |
| Disease | pulmonary fibrosis (biomarker_via_orthology) | 7.19e-04 | 50 | 103 | 3 | DOID:3770 (biomarker_via_orthology) | |
| Disease | intracranial aneurysm (is_implicated_in) | 7.78e-04 | 12 | 103 | 2 | DOID:10941 (is_implicated_in) | |
| Disease | idiopathic osteonecrosis of the femoral head | 8.06e-04 | 52 | 103 | 3 | EFO_1001930 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 8.52e-04 | 53 | 103 | 3 | C4707243 | |
| Disease | cholangiocarcinoma (biomarker_via_orthology) | 9.18e-04 | 13 | 103 | 2 | DOID:4947 (biomarker_via_orthology) | |
| Disease | putamen volume change measurement | 9.18e-04 | 13 | 103 | 2 | EFO_0021495 | |
| Disease | Diabetic Neuralgia | 1.07e-03 | 14 | 103 | 2 | C0751074 | |
| Disease | Diabetic Neuropathies | 1.07e-03 | 14 | 103 | 2 | C0011882 | |
| Disease | Asymmetric Diabetic Proximal Motor Neuropathy | 1.07e-03 | 14 | 103 | 2 | C0271674 | |
| Disease | Symmetric Diabetic Proximal Motor Neuropathy | 1.07e-03 | 14 | 103 | 2 | C0271673 | |
| Disease | Diabetic Mononeuropathy | 1.07e-03 | 14 | 103 | 2 | C0271678 | |
| Disease | Diabetic Autonomic Neuropathy | 1.07e-03 | 14 | 103 | 2 | C0271686 | |
| Disease | Diabetic Amyotrophy | 1.07e-03 | 14 | 103 | 2 | C0271685 | |
| Disease | Diabetic Polyneuropathies | 1.07e-03 | 14 | 103 | 2 | C0271680 | |
| Disease | Diabetic Asymmetric Polyneuropathy | 1.07e-03 | 14 | 103 | 2 | C0393835 | |
| Disease | hypertension (biomarker_via_orthology) | 1.22e-03 | 227 | 103 | 5 | DOID:10763 (biomarker_via_orthology) | |
| Disease | leukocyte immunoglobulin-like receptor subfamily B member 1 measurement | 1.23e-03 | 15 | 103 | 2 | EFO_0008208 | |
| Disease | brain edema (biomarker_via_orthology) | 1.23e-03 | 15 | 103 | 2 | DOID:4724 (biomarker_via_orthology) | |
| Disease | diffuse plaque measurement | 1.36e-03 | 758 | 103 | 9 | EFO_0010699 | |
| Disease | lifestyle measurement, anxiety disorder measurement | 1.38e-03 | 137 | 103 | 4 | EFO_0007795, EFO_0010724 | |
| Disease | autism spectrum disorder (is_implicated_in) | 1.40e-03 | 16 | 103 | 2 | DOID:0060041 (is_implicated_in) | |
| Disease | gestational age | 1.42e-03 | 138 | 103 | 4 | EFO_0005112 | |
| Disease | Bipolar Disorder | 1.44e-03 | 477 | 103 | 7 | C0005586 | |
| Disease | cholangiocarcinoma (is_marker_for) | 1.47e-03 | 64 | 103 | 3 | DOID:4947 (is_marker_for) | |
| Disease | Liver Cirrhosis, Experimental | 1.57e-03 | 774 | 103 | 9 | C0023893 | |
| Disease | Vascular Diseases | 1.59e-03 | 17 | 103 | 2 | C0042373 | |
| Disease | dermatomyositis (is_marker_for) | 1.59e-03 | 17 | 103 | 2 | DOID:10223 (is_marker_for) | |
| Disease | low density lipoprotein cholesterol measurement, physical activity | 1.61e-03 | 66 | 103 | 3 | EFO_0003940, EFO_0004611 | |
| Disease | Hereditary hearing loss and deafness | 1.74e-03 | 146 | 103 | 4 | cv:C0236038 | |
| Disease | rheumatoid arthritis (is_marker_for) | 1.83e-03 | 69 | 103 | 3 | DOID:7148 (is_marker_for) | |
| Disease | peak expiratory flow | 1.84e-03 | 498 | 103 | 7 | EFO_0009718 | |
| Disease | glaucoma (is_marker_for) | 2.20e-03 | 20 | 103 | 2 | DOID:1686 (is_marker_for) | |
| Disease | Osteoarthritis of hip | 2.20e-03 | 20 | 103 | 2 | C0029410 | |
| Disease | alpha-tocopherol measurement | 2.20e-03 | 20 | 103 | 2 | EFO_0007898 | |
| Disease | age at first sexual intercourse measurement | 2.29e-03 | 383 | 103 | 6 | EFO_0009749 | |
| Disease | stem Cell Growth Factor beta measurement | 2.32e-03 | 75 | 103 | 3 | EFO_0008292 | |
| Disease | Headache, HbA1c measurement | 2.43e-03 | 21 | 103 | 2 | EFO_0004541, HP_0002315 | |
| Disease | kidney disease (biomarker_via_orthology) | 2.43e-03 | 21 | 103 | 2 | DOID:557 (biomarker_via_orthology) | |
| Disease | hyperglycemia (biomarker_via_orthology) | 2.43e-03 | 21 | 103 | 2 | DOID:4195 (biomarker_via_orthology) | |
| Disease | cardiovascular system disease (is_implicated_in) | 2.43e-03 | 21 | 103 | 2 | DOID:1287 (is_implicated_in) | |
| Disease | gastric ulcer (biomarker_via_orthology) | 2.43e-03 | 21 | 103 | 2 | DOID:10808 (biomarker_via_orthology) | |
| Disease | nose morphology measurement, mouth morphology measurement | 2.43e-03 | 21 | 103 | 2 | EFO_0007843, EFO_0007955 | |
| Disease | taste liking measurement | 2.44e-03 | 388 | 103 | 6 | EFO_0010155 | |
| Disease | Disproportionate short stature | 2.51e-03 | 77 | 103 | 3 | C0878659 | |
| Disease | Alcoholic Intoxication, Chronic | 2.53e-03 | 268 | 103 | 5 | C0001973 | |
| Disease | response to angiotensin-converting enzyme inhibitor | 2.60e-03 | 78 | 103 | 3 | EFO_0005325 | |
| Disease | seminoma (is_marker_for) | 2.66e-03 | 22 | 103 | 2 | DOID:4440 (is_marker_for) | |
| Disease | Glioblastoma | 2.69e-03 | 79 | 103 | 3 | C0017636 | |
| Disease | mean platelet volume | SEMA3F SH2D6 EPM2A NPEPPS SERPINE2 SRPX2 NALF1 PVR KCNQ1 LY75 | 3.02e-03 | 1020 | 103 | 10 | EFO_0004584 |
| Disease | peptic ulcer disease, Peptic ulcer and gastro-oesophageal reflux disease (GORD) drug use measurement, gastroesophageal reflux disease | 3.17e-03 | 24 | 103 | 2 | EFO_0003948, EFO_0009923, MONDO_0004247 | |
| Disease | unipolar depression, neuroticism measurement | 3.17e-03 | 24 | 103 | 2 | EFO_0003761, EFO_0007660 | |
| Disease | Sjogren's syndrome (is_marker_for) | 3.17e-03 | 24 | 103 | 2 | DOID:12894 (is_marker_for) | |
| Disease | glioblastoma (is_implicated_in) | 3.17e-03 | 24 | 103 | 2 | DOID:3068 (is_implicated_in) | |
| Disease | systemic scleroderma (is_implicated_in) | 3.17e-03 | 24 | 103 | 2 | DOID:418 (is_implicated_in) | |
| Disease | Autism Spectrum Disorders | 3.32e-03 | 85 | 103 | 3 | C1510586 | |
| Disease | Cerebral Astrocytoma | 3.44e-03 | 25 | 103 | 2 | C0750935 | |
| Disease | Intracranial Astrocytoma | 3.44e-03 | 25 | 103 | 2 | C0750936 | |
| Disease | Astrocytoma | 3.44e-03 | 25 | 103 | 2 | C0004114 | |
| Disease | Grade I Astrocytoma | 3.44e-03 | 25 | 103 | 2 | C1704230 | |
| Disease | Subependymal Giant Cell Astrocytoma | 3.44e-03 | 25 | 103 | 2 | C0205768 | |
| Disease | Mixed oligoastrocytoma | 3.44e-03 | 25 | 103 | 2 | C0547065 | |
| Disease | colon adenocarcinoma (is_marker_for) | 3.44e-03 | 25 | 103 | 2 | DOID:234 (is_marker_for) | |
| Disease | apolipoprotein L1 measurement | 3.44e-03 | 25 | 103 | 2 | EFO_0021854 | |
| Disease | inflammatory bowel disease (implicated_via_orthology) | 3.44e-03 | 25 | 103 | 2 | DOID:0050589 (implicated_via_orthology) | |
| Disease | Pilocytic Astrocytoma | 3.44e-03 | 25 | 103 | 2 | C0334583 | |
| Disease | Juvenile Pilocytic Astrocytoma | 3.44e-03 | 25 | 103 | 2 | C0280783 | |
| Disease | Diffuse Astrocytoma | 3.44e-03 | 25 | 103 | 2 | C0280785 | |
| Disease | Childhood Cerebral Astrocytoma | 3.44e-03 | 25 | 103 | 2 | C0338070 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PAAWCINLEGSYTCQ | 521 | Q5DID0 | |
| QYNASQEWDLRSSCG | 516 | P22792 | |
| AWLNSEANYCELNPA | 421 | O75815 | |
| ANGTLNPYCVLWDDS | 811 | O60242 | |
| SCLGRLSWYDPDFQA | 21 | P06127 | |
| PDASDNVCLAWNYRD | 246 | Q3LIE5 | |
| WDYAAPNATARASCP | 71 | P48546 | |
| CSYNIGQAWNRPCEA | 1676 | Q75N90 | |
| YQINATSPWVRDLCG | 501 | O75129 | |
| PAALVANLCDDRYNW | 91 | Q8NE62 | |
| YNTNHEADDWCVPSR | 411 | Q15118 | |
| ALALQCYNPVTDAWS | 436 | Q0D2K2 | |
| IWRGPNVNCTDSSGY | 46 | Q7Z6G8 | |
| SLRCFGESEVSWQYP | 46 | P16234 | |
| DQGQWSDVPCNYHLS | 791 | Q96GW7 | |
| DGLPWCSTTANYDTD | 251 | P14780 | |
| CASSWINPDTRDQYL | 561 | Q8IVH8 | |
| DACWALSYLSDGPNE | 271 | O60684 | |
| WDIVQNSSGCNRYPE | 196 | O95278 | |
| RSVCAYDPASDSWQE | 481 | Q9H511 | |
| QTAWRCYAAENPDSS | 376 | P51787 | |
| ATYVNDPEDNNSSCW | 511 | Q5T1H1 | |
| ANLLWNCFPSYNRDS | 221 | Q8IV33 | |
| QSRIYWDGPLALCND | 331 | Q15306 | |
| DDNYCRNPDGSERPW | 206 | Q2TV78 | |
| YAWNANRIPGDDSTC | 181 | Q5VTL7 | |
| FCTRAWPSYQLQDGE | 321 | Q68D85 | |
| CTPARYEGTWSNGLQ | 101 | Q9HDC5 | |
| WSQYREGDGSCFPDA | 31 | P36222 | |
| YNSLRGEAEPCGAWV | 61 | P55899 | |
| TQQGRVPWYSEACAS | 326 | Q6UW60 | |
| RAPVAGTCYQAEWDD | 161 | P30086 | |
| YWVDPNQGCARDAFR | 1586 | P13942 | |
| YSDTRCDAGWLPNNG | 356 | O60449 | |
| FRCGSTSAPNDLWYN | 226 | P07093 | |
| YAQHWCSQLTDADGP | 626 | P98088 | |
| ENYCRNPDGSESPWC | 351 | P14210 | |
| GAPRSYLQVASAECW | 36 | A4D2B8 | |
| YLQVASAECWAAAPA | 41 | A4D2B8 | |
| YASFQGIPSAEWRIC | 71 | Q9Y693 | |
| GCNNSSWIPRGNYIE | 166 | A8MWY0 | |
| NSPDCLDYKDQASWR | 336 | P32242 | |
| VWDNGTAANYRCSGA | 51 | Q86YT6 | |
| TCWAISYLTDGPNER | 271 | P52292 | |
| GYTLEGSPWSQCQAD | 1941 | P17927 | |
| ENSDLFYAVPWSCGT | 206 | Q15392 | |
| ALSLWGQPAEAAACY | 16 | P29400 | |
| ANRWLNENYTGKVPC | 316 | P57058 | |
| NDWIRVGLCYPSNTS | 1066 | Q9UHN6 | |
| DGEYWVDPNQGCSRD | 1651 | P20908 | |
| NNGYRECLANGSWAA | 81 | P34998 | |
| ECLANGSWAARVNYS | 86 | P34998 | |
| VNNCVSYRNPAEGTW | 406 | Q14790 | |
| FWSAYVPCQTQDRDA | 131 | Q9H4A9 | |
| CQGDRNYWNAASFPN | 791 | Q9UHC6 | |
| DDNYCRNPDGSERPW | 236 | P26927 | |
| TCNIGVPWYDREAND | 136 | P13807 | |
| DVRCSGNESYLWSCP | 1706 | Q9UGM3 | |
| EPNYTVWSDLSCNLG | 646 | P55786 | |
| GPDARAWDYQACTEI | 341 | Q9UHL4 | |
| GWQVYSSAQDPDGRC | 51 | Q96PB7 | |
| ISPEDAGSYSCWVNN | 561 | P20273 | |
| RDLQFPCLTSSGAYW | 1706 | Q9P2P1 | |
| CDARSNPEPTGYNWS | 266 | P15151 | |
| DSPLSNRYAGDWSSC | 1081 | Q5VT97 | |
| QPWNVTGDSIRSYCE | 176 | P59551 | |
| VWDIRNTYCSAPADG | 536 | O75529 | |
| NVYNSWEGCPASLNE | 1701 | O75445 | |
| ADPNSGQSWYFLGRC | 276 | O14607 | |
| RWYQRCQPSDATSGL | 26 | Q8N808 | |
| AVTQGRSYWACAVDP | 586 | Q7Z4K8 | |
| DDPWTFYCQLARNAN | 996 | O60522 | |
| ARDPYCAWDGQACSR | 561 | Q13275 | |
| PTGWNCSGYDDREND | 51 | Q9UIK5 | |
| RCSGAYNLSSEWSAP | 296 | O75019 | |
| GNEYPTRTRNCWADT | 101 | A6NJ46 | |
| GYPQSTARDWLVCGD | 511 | Q9ULZ9 | |
| SAEAWCNGLPYPSQE | 176 | O15353 | |
| EDSDLLTQPWYSGNC | 56 | Q7Z4S9 | |
| LDQSRCSNYDTPAWV | 101 | B8ZZ34 | |
| ECSPWPDVAYQVNSA | 256 | Q9NZI6 | |
| ACDWLRATGFPQYAQ | 456 | Q96QB1 | |
| RPRPEWASYHNCNSN | 6 | Q8N4L4 | |
| LARDPYCAWDGNACS | 546 | O95025 | |
| DRNWYVQPSCATSGD | 146 | P62330 | |
| EEPRDWNTGRQYCHT | 116 | P0C7M8 | |
| CGFRSYWPLGTNAEN | 11 | Q9UI72 | |
| RSVQPCDNYIASFAW | 316 | Q9NXC5 | |
| QWGAEPEGSCYQTFR | 226 | Q9H0X6 | |
| YLCPNGARCATWFQD | 86 | Q9BZJ4 | |
| PRWCYTLNIQDGEAT | 56 | O60687 | |
| CYNVNWTAEALPSAE | 41 | O15067 | |
| RDWSKNQYHDCSAPG | 161 | O95858 | |
| MDCYTANWNPLGDSA | 1 | Q9H269 | |
| AQHRIAPGYNCSTWE | 86 | Q9H5I5 | |
| NNYPSEARCDWVIVA | 911 | Q9Y6L7 | |
| PLWGQPSDQNCYDDS | 386 | Q02094 | |
| QRSCLASQDPYCGWH | 526 | Q9H3T2 | |
| CNTPNEAPSDLRYSW | 346 | Q9BZZ2 | |
| ALPYWNFATGRNECD | 241 | P40126 | |
| SCSRQAWSRDNPGFE | 81 | Q13563 | |
| DWLCCQYLASAEPGA | 1381 | Q86YV5 | |
| ACPRNSQVYGAVAEW | 366 | Q63HK3 | |
| EDYRPWQLHSQGEAC | 676 | Q8WY21 | |
| IASRDPYCGWLSQGS | 526 | Q8NFY4 | |
| SDTYIPQCSTDGQWR | 756 | P01266 | |
| AWANATCPGVTYDQE | 1771 | P01266 | |
| SCNLSYPRDGWDEST | 41 | A6NMB1 | |
| WRLETCYPQGASSGQ | 166 | B1AL88 | |
| TWVRYQECDSRSNAP | 791 | Q05586 |